CS Medica A/S (NGM: CSMED)

Market Cap	131.79M
Revenue (ttm)	7.11M
Net Income (ttm)	-18.75M
Shares Out	12.32M
EPS (ttm)	-1.52
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	75,218
Open	11.31
Previous Close	10.53
Day's Range	10.02 - 11.31
52-Week Range	3.05 - 17.99
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About CS Medica

CS MEDICA A/S develops, manufactures, and commercializes over the counter medical products containing cannabinoids for the treatment of psoriasis and arthritis. It offers gels for psoriasis, arthritis, protective nasal, and wound healing; and CBD anti-hair loss serum, as well as sleep nasal sprays and pain patches. The company primarily offers its products under the CANNASEN brand name. It also acts as a distributor of other cosmeceuticals and natural cosmetics in the Nordic region. The company was incorporated in 2011 and is based in Copenhage...

• Industry: Pharmaceutical Preparations
• Founded: 2011
• Employees: 9
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: CSMED

Financial Performance

In 2023, CS Medica's revenue was 1.07 million, a decrease of -89.92% compared to the previous year's 10.58 million. Losses were -14.51 million, 34.3% more than in 2022.

Financial numbers in DKK